By Guillermo Ros Lluch
DISEASE: Crohn’s Disease
‘Coexistentia’ represents the co-existence of the body and the disease, separate from one another. The body is shown as an iron cuirass, which displays the armor that the subject constructs, piece by piece, to protect themselves from the disease. The rusted armor symbolizes the relationship between the autoimmune condition of the disease, the passage of time, and the burden carried by patients. The intestinal area was opened by the hands to unveil what is inside. The disease is represented by Rosa Valencia marble, an extremely hard, compact material with red veins, symbolizing the human body and sickness. The work captures the concept of coexistence, adaptation and an inevitable prolonged battle over time.
“I am a patient partner and I believe that we don’t have to make short or medium-term projects but we have to set out to live for the moment. It is during the most critical moments that we accept and understand each other.”
‘Perspectives – Art, Inflammation and Me’ is an initiative that brings together more than 200 artists with patients in more than 40 countries. Together, they have created a series of paintings, sculptures, photos and other artistic expressions that vividly depict — and help others understand — the impact of immune-mediated inflammatory diseases (IMIDs). Inspired by patients’ stories, independent artists and students from a number of art universities created each piece to help more people better understand the burdens associated with some of these chronic and debilitating conditions. In addition to independent artists from all parts of the world, students from more than 15 universities coordinated by the Polytechnic University of Valencia (Universitat Politecnica de Valencia) were able to add their “Perspectives.”
Select a thumbnail to see an International image and story.
More than 100 unique artistic expressions from ‘Perspectives – Art, Inflammation and Me’ debuted at the 9th Congress of the European Crohn’s and Colitis Organisation (ECCO) in Copenhagen, Denmark February 20, 2014, generously supported by AbbVie.